V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20197849 | 20152812 | 1.76 | 98.6 | Palliative (P) | 2017-01-24 | 2017-01-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101368527 |
| 20197874 | 20152813 | 1.63 | 63.2 | Palliative (P) | 2017-12-12 | 2017-12-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101769876 |
| 20197878 | 20152814 | 1.63 | 90.3 | Palliative (P) | 2020-09-24 | 2020-09-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101165640 |
| 20197882 | 20152815 | 1.85 | 83 | null | 2017-09-27 | 2018-01-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101489697 |
| 20197884 | 20152816 | 1.74 | 73.9 | null | 2016-07-26 | 2016-07-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100029507 |
| 20197887 | 20152817 | 1.54 | 78.8 | Palliative (P) | 2017-11-04 | 2017-11-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101130598 |
| 20197890 | 20152818 | 1.68 | 143.7 | Palliative (P) | 2016-08-03 | 2016-08-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100828029 |
| 20197893 | 20152819 | 1.54 | 63.2 | null | 2020-12-22 | 2020-12-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100685288 |
| 20197897 | 20152820 | 1.63 | 63.3 | null | null | 2017-10-16 | Docetaxel | 02 | null | DOCETAXEL | 100179817 |
| 20197904 | 20152821 | 1.69 | 64.1 | null | 2020-07-30 | 2020-12-16 | Docetaxel | 02 | null | DOCETAXEL | 100585064 |
| 20197909 | 20152822 | 1.55 | 74.7 | null | 2018-03-18 | 2019-09-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101011225 |
| 20197911 | 20152823 | 1.74 | 75 | null | 2016-03-30 | 2016-04-07 | Docetaxel | 02 | null | DOCETAXEL | 101263284 |
| 20197916 | 20152824 | 1.55 | 72 | Palliative (P) | 2017-08-03 | 2017-08-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101829290 |
| 20197918 | 20152825 | 1.69 | 58 | null | 2017-12-17 | 2017-12-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100752157 |
| 20197923 | 20152826 | 1.7 | 84 | Palliative (P) | 2021-09-22 | 2021-09-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100922222 |
| 20197928 | 20152827 | 1.76 | 71.8 | null | 2018-06-28 | 2018-07-07 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101540098 |
| 20197933 | 20152828 | 1.53 | null | Curative (C) | 2018-02-02 | 2018-02-09 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100253889 |
| 20197936 | 20152829 | 1.84 | 89 | Adjuvant (A) | 2021-08-14 | 2022-02-15 | Docetaxel | 02 | N | DOCETAXEL | 100445887 |
| 20197940 | 20152830 | 1.66 | 59.7 | null | 2020-02-02 | 2020-02-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101800071 |
| 20197942 | 20152831 | 1.6 | 49 | null | 2016-05-01 | 2016-05-22 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100780658 |
| 20197950 | 20152832 | 1.69 | 62.3 | Curative (C) | 2018-07-26 | 2018-08-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100824136 |
| 20197952 | 20152833 | null | 47.6 | Palliative (P) | 2017-12-29 | 2018-01-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101403826 |
| 20197953 | 20152834 | 1.53 | 51 | Palliative (P) | 2018-10-19 | 2019-01-25 | Docetaxel | 02 | N | DOCETAXEL | 101232839 |
| 20197955 | 20152835 | 1.69 | 66.9 | Palliative (P) | 2020-12-09 | 2020-12-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100085105 |
| 20197959 | 20152836 | 1.76 | 87 | Adjuvant (A) | 2018-10-15 | 2018-10-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100804722 |
| 20197963 | 20152837 | 1.66 | 66 | null | 2017-09-25 | 2018-09-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100963481 |
| 20197965 | 20152838 | 1.72 | 69.1 | Palliative (P) | 2018-08-30 | 2018-09-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101858125 |
| 20197977 | 20152839 | 1.6 | 91.4 | Palliative (P) | 2016-07-18 | 2016-08-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101048433 |
| 20197981 | 20152840 | 1.85 | 56.5 | null | 2017-02-06 | 2017-03-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100840086 |
| 20197985 | 20152841 | 1.7 | 70.8 | Adjuvant (A) | 2016-10-13 | 2016-10-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100733242 |
| 20197988 | 20152842 | 1.66 | 64.3 | Palliative (P) | 2016-11-02 | 2017-01-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101214063 |
| 20197996 | 20152843 | 1.74 | 67.3 | null | 2016-07-16 | 2016-09-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100211812 |
| 20198001 | 20152844 | 1.81 | 83 | Palliative (P) | 2016-05-18 | 2016-06-06 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 100599661 |
| 20198003 | 20152845 | 1.48 | 71.6 | null | 2021-02-15 | 2021-02-18 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101369660 |
| 20198009 | 20152846 | 1.74 | 55 | Palliative (P) | 2017-10-03 | 2017-10-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101486321 |
| 20198017 | 20152847 | 1.84 | 58.8 | Palliative (P) | 2016-12-08 | 2016-12-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101243259 |
| 20198018 | 20152848 | null | 60 | Palliative (P) | 2019-01-08 | 2019-02-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100764418 |
| 20198021 | 20152849 | 1.9 | 76 | null | 2017-04-16 | 2018-06-29 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100421316 |
| 20198027 | 20152850 | 1.82 | 81.1 | null | 2018-05-09 | 2018-08-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100643608 |
| 20198029 | 20152851 | 1.61 | null | Neo-adjuvant (N) | 2019-07-15 | 2019-07-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101538637 |
| 20198033 | 20152852 | 1.68 | 90.55 | Adjuvant (A) | 2016-11-14 | 2016-11-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100893657 |
| 20198034 | 20152853 | 2 | 85.6 | Palliative (P) | null | 2019-11-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101376301 |
| 20198035 | 20152854 | 1.7 | 88.9 | Neo-adjuvant (N) | 2017-03-25 | 2017-04-16 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101286579 |
| 20198039 | 20152855 | 1.86 | 50.3 | null | 2016-12-01 | 2017-03-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100914155 |
| 20198040 | 20152856 | 1.52 | 57.5 | null | 2018-12-03 | 2018-12-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100370129 |
| 20198042 | 20152857 | 1.76 | 119 | null | 2018-01-25 | 2018-02-03 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100069948 |
| 20198044 | 20152858 | 1.59 | 78 | Neo-adjuvant (N) | 2019-12-05 | 2019-12-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101099298 |
| 20198047 | 20152859 | 1.93 | 102 | null | 2017-11-21 | 2017-12-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101611102 |
| 20198050 | 20152860 | null | 54.9 | Palliative (P) | 2020-02-13 | 2020-03-10 | Docetaxel | 02 | N | DOCETAXEL | 101098462 |
| 20198051 | 20152861 | 1.9 | 59.9 | Palliative (P) | 2017-10-26 | 2020-01-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100550860 |